0%
Daily Market Update
29-Apr-20261 min readvipin kumar

Brent crude prices pause near $111 amid fragile US-Iran ceasefire talks- Daily Market Update 29th April 2026

Get a Smart Summary Instantly

Prompt copied

Oil prices paused after a sharp climb, as markets tracked uncertain diplomatic signals around the Iran conflict and the fate of the Strait of Hormuz — a chokepoint that remains effectively shut. Brent crude hovered near $111 a barrel after gaining roughly 2.8% in the previous session, while West Texas Intermediate (WTI) traded just above $99. The price action reflects a market caught between tentative ceasefire developments and the reality of constrained Middle East supply.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled on a flat to negative note.
  • European equity markets too ended on a flat to negative note.
  • Asian equity markets are trading mix.
  • GIFT Nifty is little changed, Nifty futures likely to open around 24100 levels.

 

News highlights from across the globe

  • US indices settled lower on Tuesday, backing away from record closing highs as ​renewed concerns over the artificial intelligence boom weighed on technology stocks days before five of the sector’s most high-profile companies were due to post quarterly ‌results.
  • Asian markets are trading lower after a tech-led selloff hit Wall Street as concerns mounted over returns from the billions spent on artificial intelligence ahead of a slew of megacap company earnings.
  • Brent crude hovered near $111 a barrel after gaining roughly 2.8% in the previous session

 

Important news updates from the domestic front

  • Bandhan Bank Q4 FY26 (YoY) Revenue (NII) up 1% at Rs 2,796 crore versus Rs 2,756 crore. Margin (NIM) up 30 bps to 6.2%. Net Profit up 68% at Rs 534 crore versus Rs 318 crore;Provisions at Rs 677 crore versus Rs 1,260.2 crore YoY and Rs 1,154 crore QoQ. Gross NPA at 3.27% versus 3.33% QoQ. Net NPA at 0.97% versus 0.99% QoQ. Fresh slippages at Rs 10,300 crore versus Rs 13,100 crore QoQ and Rs 17,500 crore YoY.
  • CEAT Q4 FY26 (Cons, YoY) Revenue up 23.3% at Rs 4,219 crore versus Rs 3,421 crore. EBITDA up 52.7% at Rs 593 crore versus Rs 388 crore. EBITDA margin at 14% versus 11.3%. Net Profit at Rs 244 crore versus Rs 99 crore; to pay dividend of Rs 35/share.
  • Garden Reach Shipbuilders Q4 FY26 (YoY)Revenue up 29.1% at Rs 2,119 crore versus Rs 1,642 crore. EBITDA up 61% at Rs 355 crore versus Rs 221 crore. EBITDA margin at 16.8% versus 13.4%. Net Profit up 24.1% at Rs 303 crore versus Rs 244 crore; to pay final dividend of Rs 6.7/share.
  • RVNL receives a construction order worth Rs. 39 crore from NMDC.
  • Greenply Industries announces the resignation of Manoj Tulsian as Joint Managing Director and CEO.
  • Solara Active Pharma Sciences informs that the US FDA has concluded an inspection at its Puducherry facility, classifying the unit as VAI and issuing four procedural FDA‑483 observations.
  • PC Jewellers arm, PCJ Mining, receives a one‑year gold‑mining licence in Chad.
  • Mobikwik Peak XV Partners Investments sells 62.2 lakh shares in the company at a price of Rs. 214 per share, as per exchange data.
  • Quess Corp receives an income‑tax refund of Rs. 42.24 crore for FY24.
  • Neogen Chemicals‘s arm, Neogen Ionics, will invest Rs. 100.1 crore in its step‑down subsidiary, Neogen Morita New Material, through a rights issue. Under the issue, 71 lakh shares will be allotted at Rs. 141 per share. The funds will be used to support lithium‑ion battery materials business.
  • Kiri Industries receives warning letters from BSE and NSE over delayed disclosures related to the sale of its DyStar stake.
  • BHEL signs a transfer‑of‑technology agreement with DRDO’s NSTL unit. Under the pact, BHEL will develop infra‑red suppression systems for naval vessels using GT‑IRSS technology.
  • Cupid receives a warning letter from SEBI for failure to disclose the cancellation of a preferential issue.
  • Onesource Specialty Pharma receives EU‑GMP approval for its sterile product division at its Bengaluru facility. The certification covers aseptic sterile injectable products, and the division has already been approved by the US FDA and Health Canada.
  • Ujjivan Small Finance Bank will consider raising funds through QIP or other modes at its meeting scheduled on May 8.

 

Nifty Overview & Outlook

Tracking negative cues from the global front, benchmark Nifty index opened with a gap on the lower side and settled at 23995.70 spot levels after a cut of 97 points from its previous closing values.

Broader markets outperformed the benchmark as Mid and Small cap indices rose 0.26% and 0.42% respectively against negative closing of frontline index.

Majority of sectoral indices, tracked at NSE, ended in red. Amongst them, Nifty PSU Bank index was at the bottom of the tally, down over 2% followed by Auto, Banking & Finance, IT and Realty indices that were down in range 0.42% to 1.24%. On the other hand, Oil & Gas index was the top performer, rose over 1.5%.

Technically, Overall chart structure for Nifty index is showing signs of consolidation within a broader range, with downside supports around 23800-23550 spot levels and resistance near the 24300-24500 spot zone (as already discussed in our previous note dated April 28, 2026). Considering current chart structure, we suggest traders to buy the sip around the support zones and sell around the resistance zone. Intraday support is placed around 23950-23900 spot levels while intraday resistance are at 24150-24225 spot levels.

 

Derivatives Overview & Outlook

Yesterday, all index futures, barring Midcapnifty, settled lower on long unwinding as traders cut down some of their long positions on scheduled monthly expiry.

Nifty and Banknifty futures rolled 71%& 79% of open interest respectively into next contracts which is slightly lower than previous month rollovers of 78% & 86% respectively.

On options front, Nifty will start the first weekly series of May contracts with maximum positions at 23000 PE and 25000 CE.

 

Institutional Trading Activity

Yesterday, FIIs sold stocks worth Rs 2104 Cr in the cash segment, sold stocks futures worth Rs 3064 Cr also sold index future worth Rs 3094 Cr. DIIs were net buyers to the tune of Rs 1712 Cr in the cash segment.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 24250-24350; Supports 24000-23800

Banknifty – Resistances 56200-56600; Supports 55500-55000

Finnifty – Resistances 26200-26400; Supports 22980- 25850

 

F&O stocks in ban today: SAIL

 

Important Results Today: ADANIPOWER, BAJFINANCE,  FEDERALBNK, GRANULES, IIFL, MPHASIS, SYNGENE & VEDL

 

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates. AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited and Lakshya Impex Private Limited are the associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection GC does not take any responsibility thereof. This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months. GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months. Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document. Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Our research analysts may use AI tools to collect, summarize, and present data in order to increase productivity and enhance the clarity and readability of our reports. However, all reports are subject to human review prior to finalization and distribution to end users.

Our published research reports are the property of GCML and its associate and subsidiary companies. These reports may not be copied, reproduced, distributed or otherwise used by any other brokerage or individual firm without the prior written permission of GCML or its associate/subsidiary companies.